| Symbol |
Name |
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMH
|
anti-Mullerian hormone
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
AURKA
|
aurora kinase A
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B3GNT3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator)
|
|
BSG
|
basigin (Ok blood group)
|
|
BTG3
|
BTG family, member 3
|
|
CA2
|
carbonic anhydrase II
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CALR
|
calreticulin
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD5
|
CD5 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC42
|
cell division cycle 42
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CISH
|
cytokine inducible SH2-containing protein
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLOCK
|
clock circadian regulator
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRTC3
|
CREB regulated transcription coactivator 3
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EHD1
|
EH-domain containing 1
|
|
EIF3A
|
eukaryotic translation initiation factor 3, subunit A
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EP300
|
E1A binding protein p300
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
EPPIN
|
epididymal peptidase inhibitor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRP1
|
epithelial splicing regulatory protein 1
|
|
ETV1
|
ets variant 1
|
|
ETV6
|
ets variant 6
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F13B
|
coagulation factor XIII, B polypeptide
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FERMT2
|
fermitin family member 2
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXA1
|
forkhead box A1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FTO
|
fat mass and obesity associated
|
|
GCG
|
glucagon
|
|
GHR
|
growth hormone receptor
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLI3
|
GLI family zinc finger 3
|
|
GNMT
|
glycine N-methyltransferase
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOGA1
|
4-hydroxy-2-oxoglutarate aldolase 1
|
|
HP
|
haptoglobin
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPSE
|
heparanase
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNL4
|
interferon, lambda 4 (gene/pseudogene)
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
ING5
|
inhibitor of growth family, member 5
|
|
INSR
|
insulin receptor
|
|
IRF1
|
interferon regulatory factor 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
KCTD10
|
potassium channel tetramerization domain containing 10
|
|
KDR
|
kinase insert domain receptor
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK8
|
kallikrein-related peptidase 8
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LPL
|
lipoprotein lipase
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEFV
|
Mediterranean fever
|
|
MEIS1
|
Meis homeobox 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR135B
|
microRNA 135b
|
|
MIR17
|
microRNA 17
|
|
MIR20A
|
microRNA 20a
|
|
MIR503
|
microRNA 503
|
|
MIR650
|
microRNA 650
|
|
MLH1
|
mutL homolog 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MSMB
|
microseminoprotein, beta-
|
|
MSTN
|
myostatin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NANOG
|
Nanog homeobox
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NRCAM
|
neuronal cell adhesion molecule
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
OLFM1
|
olfactomedin 1
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PBX3
|
pre-B-cell leukemia homeobox 3
|
|
PDCD5
|
programmed cell death 5
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIP
|
prolactin-induced protein
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLD2
|
phospholipase D2
|
|
PON1
|
paraoxonase 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PROM1
|
prominin 1
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
RB1
|
retinoblastoma 1
|
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
REPS2
|
RALBP1 associated Eps domain containing 2
|
|
RET
|
ret proto-oncogene
|
|
RHOA
|
ras homolog family member A
|
|
RHOQ
|
ras homolog family member Q
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100P
|
S100 calcium binding protein P
|
|
SCARA3
|
scavenger receptor class A, member 3
|
|
SCGB2A1
|
secretoglobin, family 2A, member 1
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIRT3
|
sirtuin 3
|
|
SIX2
|
SIX homeobox 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNX10
|
sorting nexin 10
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPDYA
|
speedy/RINGO cell cycle regulator family member A
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAU1
|
staufen double-stranded RNA binding protein 1
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STK11
|
serine/threonine kinase 11
|
|
TCF3
|
transcription factor 3
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLE3
|
transducin-like enhancer of split 3
|
|
TLR3
|
toll-like receptor 3
|
|
TMEM25
|
transmembrane protein 25
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPO
|
thyroid peroxidase
|
|
TYMP
|
thymidine phosphorylase
|
|
UTS2
|
urotensin 2
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZNHIT3
|
zinc finger, HIT-type containing 3
|
